Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.027
Neutral
RSI(14)
57.332
Neutral
STOCH(KDJ)(9,3,3)
76.776
Buy
ATR(14)
0.663
High Vlolatility
CCI(14)
81.591
Neutral
Williams %R
9.239
Overbought
TRIX(12,20)
0.247
Sell
StochRSI(14)
100.000
Buy
Progyny Inc
PGNYView Detailed Chart
23.500USD
+0.670+2.93%
Close 07/30, 16:00（ET）Quotes delayed by 15 min
2.01BMarket Cap
38.35P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.93%
5 Days
+2.26%
1 Month
+7.26%
6 Months
-0.17%
Year to Date
+36.23%
1 Year
-19.02%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
10
analysts
BUY
Current Rating
27.286
Target Price
19.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
7
Total
19
Median
16
Average
Company name
Ratings
Analysts
Progyny Inc
PGNY
10
Humana Inc
HUM
27
Elevance Health Inc
ELV
24
Centene Corp
CNC
21
Molina Healthcare Inc
MOH
19
Alignment Healthcare Inc
ALHC
12
1
2
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Moving Average
Indicators
Value
Direction
MA5
23.128
Buy
MA10
23.003
Buy
MA20
22.939
Buy
MA50
22.035
Buy
MA100
22.008
Buy
MA200
20.063
Buy
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Ticker SymbolPGNY
CompanyProgyny Inc
CEOMr. Peter (Pete) Anevski
Websitehttps://www.progyny.com/
